Entero Healthcare Solutions Ltd (ENTERO) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Entero Healthcare Solutions Ltd. reported strong Q1 FY26 results, with revenue up 28% YoY to Rs. 1,404 crores, driven by both organic (15% like-to-like) and inorganic growth.
- Gross profit increased 40% YoY to Rs. 140 crores, with gross margins expanding by 83 basis points YoY to 9.9%.
- EBITDA grew 66% YoY to Rs. 50 crores, with margins up 82 basis points YoY to 3.6%.
- The company continues to focus on cash flow optimization, reducing net working capital days from 71 to 66, with a target of 60 days by the end of FY26.
- Entero expanded its network to 71,000 retail pharmacies and 2,500 hospitals across 469 districts, offering over 74,700 SKUs from 2,600 manufacturers.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.